Cargando…
miR-15a and miR-15b modulate natural killer and CD8(+)T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma
Neuroblastoma (NB) is an enigmatic and deadliest pediatric cancer to treat. The major obstacles to the effective immunotherapy treatments in NB are defective immune cells and the immune evasion tactics deployed by the tumor cells and the stromal microenvironment. Nervous system development during em...
Autores principales: | Pathania, Anup S., Prathipati, Philip, Olwenyi, Omalla A., Chava, Srinivas, Smith, Oghenetejiri V., Gupta, Subash C., Chaturvedi, Nagendra K., Byrareddy, Siddappa N., Coulter, Don W., Challagundla, Kishore B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133764/ https://www.ncbi.nlm.nih.gov/pubmed/35663229 http://dx.doi.org/10.1016/j.omto.2022.03.010 |
Ejemplares similares
-
miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma
por: Chava, Srinivas, et al.
Publicado: (2019) -
Amino Acids Regulate Cisplatin Insensitivity in Neuroblastoma
por: Gunda, Venugopal, et al.
Publicado: (2020) -
A mutation in porcine pre-miR-15b alters the biogenesis of MiR-15b\16-1 cluster and strand selection of MiR-15b
por: Sun, Wenyang, et al.
Publicado: (2017) -
Dysregulation of miR-15a and miR-214 in human pancreatic cancer
por: Zhang, Xing J, et al.
Publicado: (2010) -
miR-15b and miR-21 as Circulating Biomarkers for Diagnosis of Glioma
por: Ivo D’Urso, Pietro, et al.
Publicado: (2015)